Loading...
Loading...
By Sofía Garduño - Thu, 03/05/2026 - 11:36
This week, INEGI indicates a decline in healthcare access, while the medical device industry plans to mobilize up to US$400 million in investment.
Featured content
Mon, 01/05/2026 - 08:30
Scaling functional medicine in Mexico requires ecosystem models and precision health to fight chronic disease, writes Gustavo Rodríguez.
https://mexicobusiness.news/tag/cofepris
More Health
By Sandra Sánchez-Oldenhage - Tue, 03/03/2026 - 08:30
Latin American family pharma must institutionalize governance and professionalize to scale amid regulatory complexity, writes Sandra Sanchez.
By MBN Staff - Mon, 03/02/2026 - 13:07
Mexico’s COFEPRIS has unveiled a new regulatory model to spur innovation, curb counterfeit drugs.
By Aura Moreno - Fri, 02/27/2026 - 11:51
Mexico’s medical device industry plans US$400 million in investments by 2030, in alignment with Plan México and USMCA dynamics.
By Sofía Garduño - Tue, 02/24/2026 - 10:03
Illegal online pharmacies and organized crime are driving a surge in counterfeit medicines in Mexico and major markets.
By Oswaldo Bernal - Mon, 02/23/2026 - 08:30
Plan México and AI-driven clinical research leverage 'creative destruction' to transform national health. Oswaldo Bernal explains.
By César Marrón - Tue, 02/17/2026 - 07:30
Mexico is shifting to value-based healthcare, prioritizing efficiency, digital ecosystems, and ethical governance for growth, writes Cesar Marrón.
By Victor Gabriel Sánchez - Fri, 02/13/2026 - 06:00
A Mexican pivot to pharma and medical devices can bolster supply chains amid USMCA and auto sector shifts, writes Victor Gabriel Sanchez.
By David López García - Thu, 02/12/2026 - 09:00
Mexico’s rare disease ecosystem needs structural action — not just slogans — to end the diagnostic odyssey for millions, writes David Lopez.
By Erick Ponce Flores - Thu, 02/12/2026 - 07:30
As COFEPRIS leadership shifts, prohibition and regulatory inconsistency risk Mexico's public health, writes Erick Ponce.
